B Cell Non Hodgkin Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Beijing, Beijing, China
  • +20 more
2022-03-22
Mar 22, 2022
A
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS 7)
Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Loncastuximab Tesirine
  • +4 more
  • (no location specified)
2022-03-28
Mar 28, 2022
U
Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022
N
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas
Not yet recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • (no location specified)
2022-03-30
Mar 30, 2022
F
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Anakinra
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-08
Mar 8, 2022
R
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2022-03-17
Mar 17, 2022
H
A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma
Active, not recruiting
  • B-cell Non-Hodgkin Lymphoma
  • Birmingham, Alabama
  • +40 more
2022-03-17
Mar 17, 2022
H
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
Recruiting
  • B-cell Non-Hodgkin Lymphoma
  • Mosunetuzumab (IV)
  • +3 more
  • Birmingham, Alabama
  • +20 more
2022-03-17
Mar 17, 2022
G
First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Recruiting
  • B-cell Non-Hodgkin Lymphoma
  • GEN3009
  • Epcoritamab
  • Denver, Colorado
  • +27 more
2021-12-13
Dec 13, 2021
W
Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
2021-11-23
Nov 23, 2021
A
Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies - 2021
Completed
  • Relapsed or Refractory Haematological Malignancies Including
  • +10 more
  • Aachen, Germany
  • +11 more
2021-10-21
Oct 21, 2021
C
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Informational Intervention
  • +3 more
  • Oakland, California
  • +32 more
2021-09-02
Sep 2, 2021
R
TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-OX40 Antibody BMS 986178
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
2021-08-16
Aug 16, 2021
M
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies
Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-08-06
Aug 6, 2021
M
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Active, not recruiting
  • B-cell Non-Hodgkin Lymphoma
  • Aggressive
  • collected at pre-treatment tumor biopsy
  • +2 more
  • Miami, Florida
  • +11 more
2021-07-16
Jul 16, 2021
J
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma - 2018
Terminated
  • Absence of Signs or Symptoms
  • +7 more
  • Biospecimen Collection
  • +7 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2021-07-12
Jul 12, 2021
U
Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
Recruiting
  • Classical Hodgkin Lymphoma
  • +3 more
  • Chicago, Illinois
    University of Chicago
2021-06-29
Jun 29, 2021
R
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma - 2021
Completed
Has Results
  • Acute Myeloid Leukemia
  • +6 more
  • Anti-Thymocyte Globulin
  • +5 more
  • Stanford, California
    Stanford University, School of Medicine
2021-06-01
Jun 1, 2021
N
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +7 more
  • Chicago, Illinois
  • +3 more
2021-03-26
Mar 26, 2021
U
Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma
Unknown status
  • B-cell Non-Hodgkin Lymphoma
  • Welgenaleucel
  • Taipei, Taiwan
    Tri-Service General Hospital
2021-01-16
Jan 16, 2021
A
Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL - 2016
Terminated
Has Results
  • B-cell Non-Hodgkin Lymphoma
  • Duarte, California
  • +2 more
2020-11-02
Nov 2, 2020
A
A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL - 2016
Terminated
Has Results
  • B-cell Non-Hodgkin Lymphoma
  • Duarte, California
  • +4 more
2020-11-02
Nov 2, 2020
F
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma - 2019
Completed
Has Results
  • Adult Diffuse Large B-Cell Lymphoma
  • +5 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
2020-03-03
Mar 3, 2020
P
A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects - 2020
Completed
  • B-cell Non-Hodgkin Lymphoma
  • CD19-directed CAR-T cells
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
2020-03-03
Mar 3, 2020
F
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia - 2018
Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +13 more
  • Platelet Transfusion
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2019-10-17
Oct 17, 2019